BamSEC and AlphaSense Join Forces
Learn More

Sonnet BioTherapeutics Holdings Inc.

NASDAQ: SONN    
Share price (12/24/24): $1.42    
Market cap (12/24/24): $4.271 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 69 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 62 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 36 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]” License Agreement Between Sonnet Biotherapeutics, Inc and Alkem Laboratories Limited Dated as of October 8, 2024
12/34/56
EX-10.1
from 8-K 8 pages Sonnet Biotheraepeutics Holdings, Inc. June 19, 2024
12/34/56
EX-10.2
from 8-K 18 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 54 pages Chef Purchase Agreement
12/34/56
EX-10.1
from 8-K 42 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 16 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 27 pages Securities Purchase Agreement
12/34/56
EX-10.24
from 10-K 6 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. the Omissions Have Been Indicated by “[***]” Amendment to License Agreement and Settlement
12/34/56
EX-10.23
from 10-K 2 pages Second Amendment to License Agreement
12/34/56
EX-10.22
from 10-K 2 pages First Amendment to License Agreement
12/34/56
EX-10.1
from 10-Q 40 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. the Omissions Have Been Indicated by “[***]”. License Agreement Between Sonnet Biotherapeutics, Inc and New Life Therapeutics Pte, Ltd. Dated as of May 2, 2021
12/34/56
EX-10.19
from 10-K 16 pages Indemnification Agreement
12/34/56
EX-10.18
from 10-K 2 pages Amendment No. 1 to Executive Employment Agreement
12/34/56
EX-10.17
from 10-K 2 pages Amendment No. 1 to Executive Employment Agreement
12/34/56
EX-10.16
from 10-K 2 pages Assignment and Assumption Agreement
12/34/56
EX-10.1
from 8-K 12 pages Warrant Exercise and Omnibus Amendment Agreement
12/34/56
EX-10.1
from 8-K 7 pages Restricted Stock Unit Award Agreement Sonnet BioTherapeutics Holdings, Inc
12/34/56
EX-10.7
from 8-K 14 pages Material contract
12/34/56